VISTAGEN THERAPEUTICS INC (VTGN)
US92840H4002 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.11M 1.83% | -230K -120.72% | 1.064M 562.61% | 654.585K -38.48% | 321.3K -50.92% | 4.716M 1,367.79% | 71.248M 1,410.77% | 265.58M 272.75% | 536.34M 101.95% | 880.53M 64.17% | |
| EBITDA YoY % growth | -47.63M -167.43% | -59.14M -24.17% | -32.894M 44.38% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -47.78M -166.48% | -59.27M -24.05% | -33.021M 44.29% | -62.618M -89.63% | -82.305M -31.44% | -93.696M -13.84% | -53.219M 43.20% | 64.695M 221.56% | 264.95M 309.54% | 516.23M 94.84% | |
| Operating Margin | -4,304.50% | 25,769.57% | -3,103.48% | -9,566.07% | -25,616.19% | -1,986.77% | -74.69% | 24.36% | 49.40% | 58.63% | |
| EPS YoY % growth | -2.86 -633.33% | -8.65 -202.45% | N/A 81.16% | -1.87 -14.71% | -1.93 -3.41% | -2.09 -8.18% | -1.03 50.73% | 1.25 221.78% | 5.01 299.19% | 9.41 87.98% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.52 -136.45% | -0.56 -125.42% | -0.55 -55.91% | -0.60 -42.07% | -0.56 -6.86% | -0.58 -3.17% |
| Revenue Q2Q % growth | 210.803K -48.76% | 210.803K 7.01% | 234.6K 179.29% | 178.5K -2.46% | 132.6K -37.10% | 102K -51.61% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -16.619M -110.80% | -19.092M -68.08% | -21.114M -74.05% | -23.256M -63.46% | -25.5M -53.44% | -27.642M -44.78% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.42 36.36% | -0.40 | -0.02 | -5.58% |
| Q1 2025 Q2Q % growth | -0.35 -1,043.79% | -0.41 | 0.06 | 15.27% |
| Q4 2024 Q2Q % growth | -0.25 85.71% | -0.37 | 0.12 | 32.39% |
| Q3 2024 Q2Q % growth | -0.22 85.33% | -0.31 | 0.09 | 28.70% |
| Q2 2024 Q2Q % growth | -0.66 72.50% | -0.69 | 0.03 | 4.84% |
| Q1 2024 Q2Q % growth | 98.98% | -0.03 | % | |
| Q4 2023 Q2Q % growth | -1.75 35.19% | -1.53 | -0.22 | -14.38% |
| Q3 2023 Q2Q % growth | -1.50 -2,900.00% | -2.14 | 0.64 | 29.97% |
| Q2 2023 Q2Q % growth | -2.40 -3,328.57% | -2.04 | -0.36 | -17.64% |
| Q1 2023 Q2Q % growth | -3.00 -7,400.00% | -2.30 | -0.71 | -30.72% |
| Q4 2022 Q2Q % growth | -2.70 -1,250.00% | -1.76 | -0.94 | -53.45% |
| Q3 2022 Q2Q % growth | -0.05 28.57% | -0.07 | 0.02 | 32.39% |
| Q2 2022 Q2Q % growth | -0.07 -40.00% | -0.06 | -0.01 | -19.35% |
| Q1 2022 Q2Q % growth | -0.04 42.86% | -0.05 | 0.01 | 26.47% |
| Q4 2021 Q2Q % growth | -0.20 -185.71% | -0.05 | -0.15 | -292.16% |
| Q3 2021 Q2Q % growth | -0.07 53.33% | -0.05 | -0.02 | -28.68% |
| Q2 2021 Q2Q % growth | -0.05 61.54% | -0.02 | -0.03 | -110.11% |
| Q1 2021 Q2Q % growth | -0.07 53.33% | -0.13 | 0.06 | 45.10% |
| Q4 2020 Q2Q % growth | -0.07 58.82% | -0.08 | 0.01 | 14.22% |
| Q3 2020 Q2Q % growth | -0.15 37.50% | -0.07 | -0.08 | -110.08% |
| Q2 2020 Q2Q % growth | -0.13 56.67% | -0.14 | 0.01 | 5.59% |
| Q1 2020 Q2Q % growth | -0.15 25.00% | -0.11 | -0.04 | -33.69% |
| Q4 2019 Q2Q % growth | -0.17 | -0.12 | -0.05 | -38.89% |
| Q3 2019 Q2Q % growth | -0.24 | -0.22 | -0.02 | -9.44% |
| Q2 2019 Q2Q % growth | -0.30 | -0.17 | -0.13 | -73.01% |
| Q1 2019 Q2Q % growth | -0.20 | -0.14 | -0.06 | -40.06% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 183K -34.10% | 227.797K | -44.797K | -19.67% |
| Q1 2025 Q2Q % growth | 84K -53.33% | 306K | -222K | -72.55% |
| Q4 2024 Q2Q % growth | 197K 12.19% | 206.805K | -9.805K | -4.74% |
| Q3 2024 Q2Q % growth | 411.4K 128.56% | 555.39K | -143.99K | -25.93% |
| Q2 2024 Q2Q % growth | 277.7K 131.20% | 181.56K | 96.14K | 52.95% |
| Q1 2024 Q2Q % growth | 180K -41.94% | 188.7K | -8.7K | -4.61% |
| Q4 2023 Q2Q % growth | 175.6K 339.00% | 175.6K | % | |
| Q3 2023 Q2Q % growth | 180K -50.00% | 158.1K | 21.9K | 13.85% |
| Q2 2023 Q2Q % growth | -890K -347.22% | 316.2K | -1.206M | -381.47% |
| Q1 2023 Q2Q % growth | 310K -11.43% | 345.27K | -35.27K | -10.22% |
| Q4 2022 Q2Q % growth | 40K -90.91% | 359.723K | -319.723K | -88.88% |
| Q3 2022 Q2Q % growth | 360K 16.13% | 259.08K | 100.92K | 38.95% |
| Q2 2022 Q2Q % growth | 360K 9.09% | 268.77K | 91.23K | 33.94% |
| Q1 2022 Q2Q % growth | 350K | 388.283K | -38.283K | -9.86% |
| Q4 2021 Q2Q % growth | 440K | 233.07K | 206.93K | 88.78% |
| Q3 2021 Q2Q % growth | 310K | 215.557K | 94.443K | 43.81% |
| Q2 2021 Q2Q % growth | 330K | 1.7M | -1.37M | -80.59% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 12.07% | 0% | -6.08% |
| Revenue | 0% | N/A | -6.86% | -8.32% |